This is the authors' abstract. We don't add key points for this paper.
Genomics has entered a phase in which AI agents can autonomously discover, configure, execute, and chain bioinformatics operations from natural-language instructions. We term this paradigm "agentic genomics": the delegation of multi-step genomic analyses to autonomous software agents that select tools, manage dependencies, and adapt execution in response to intermediate results, mediated by large language models (LLMs) and constrained by domain-specific skill libraries. We argue that agentic genomics shifts the bottleneck in computational biology from pipeline construction to validation. We examine emerging systems, including CellAtria, AutoBA, Bio-Copilot, and ClawBio, and assess their divergent architectures. We propose a tiered validation framework spanning research-grade, benchmarked, and clinical-grade analyses and argue that equity-aware design must be a systems requirement rather than an optional aspiration. We identify the infrastructure needed to make agentic genomics trustworthy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Corpas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: